Search research articles
Contact Us
Filters
Showing results (111-120 of 198) with videos related to
Page
of 20
Sort By:
Scandinavian Journal of Immunology
|
April 1, 1988
Differences between primed allogeneic T-cell responses and the primary mixed leucocyte reaction. Primed T cells become independent of the blocking effects of monoclonal antibodies against IL-1 beta and the CD5, CD11a (LFA-1), and CD11c (p 150,95) molecules
N Odum, B Hofmann, N Morling, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1995
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
H O Madsen, P Garred, S Thiel, et al.
Genetic Epidemiology
|
January 1, 1985
The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis
A Green, A Svejgaard, P Platz, et al.
Scandinavian Journal of Immunology
|
September 1, 1985
The immunodeficiency of bone marrow-transplanted patients. The effect of patient lymphocytes on the response of donor lymphocytes to mitogens and allogeneic cells
N Odum, B Hofmann, P Platz, et al.
Lancet (London, England)
|
July 17, 1976
Letter: Association between HLA-B8 and autoimmunity in juvenile diabetes mellitus
M Christy, J Nerup, G F Bottazzo, et al.
Immunogenetics
|
January 1, 1994
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
H O Madsen, P Garred, J A Kurtzhals, et al.
Tissue Antigens
|
January 1, 1986
HLA-DP related suppression of mixed lymphocyte reaction with alloactivated lymphocytes
N Odum, B Hofmann, B K Jakobsen, et al.
International Journal of Cancer
|
August 15, 1990
Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities
M Melbye, J Palefsky, J Gonzales, et al.
Journal of Immunological Methods
|
January 29, 2000
Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
C Nyvold, H O Madsen, L P Ryder, et al.
Neurology
|
May 5, 2010
Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response
D Hesse, M Krakauer, H Lund, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 198) with videos related to
Sort By:
Page
of 20
Scandinavian Journal of Immunology
|
April 1, 1988
Differences between primed allogeneic T-cell responses and the primary mixed leucocyte reaction. Primed T cells become independent of the blocking effects of monoclonal antibodies against IL-1 beta and the CD5, CD11a (LFA-1), and CD11c (p 150,95) molecules
N Odum, B Hofmann, N Morling, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1995
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
H O Madsen, P Garred, S Thiel, et al.
Genetic Epidemiology
|
January 1, 1985
The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis
A Green, A Svejgaard, P Platz, et al.
Scandinavian Journal of Immunology
|
September 1, 1985
The immunodeficiency of bone marrow-transplanted patients. The effect of patient lymphocytes on the response of donor lymphocytes to mitogens and allogeneic cells
N Odum, B Hofmann, P Platz, et al.
Lancet (London, England)
|
July 17, 1976
Letter: Association between HLA-B8 and autoimmunity in juvenile diabetes mellitus
M Christy, J Nerup, G F Bottazzo, et al.
Immunogenetics
|
January 1, 1994
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
H O Madsen, P Garred, J A Kurtzhals, et al.
Tissue Antigens
|
January 1, 1986
HLA-DP related suppression of mixed lymphocyte reaction with alloactivated lymphocytes
N Odum, B Hofmann, B K Jakobsen, et al.
International Journal of Cancer
|
August 15, 1990
Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities
M Melbye, J Palefsky, J Gonzales, et al.
Journal of Immunological Methods
|
January 29, 2000
Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
C Nyvold, H O Madsen, L P Ryder, et al.
Neurology
|
May 5, 2010
Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response
D Hesse, M Krakauer, H Lund, et al.
Page
of 20